MARKET

EDTXF

EDTXF

Spectral Med
OTCPK
0.930
NaN%
Closed 09:30 12/24 EST
OPEN
--
PREV CLOSE
0.916
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
1.280
52 WEEK LOW
0.354
MARKET CAP
268.92M
P/E (TTM)
-8.8910
1D
5D
1M
3M
1Y
5Y
1D
Spectral Medical Reports Positive Trial Results and Revenue Growth
TipRanks · 11/21 04:06
Spectral Medical Reports Positive Tigris Trial Results and Prepares for FDA Submission
TipRanks · 11/07 13:09
Spectral Medical Announces Third Quarter 2025 Financial Results and Provides Corporate Update
Barchart · 11/07 06:30
Spectral Medical Files Base Shelf Prospectus to Raise $100 Million
TipRanks · 09/29 15:38
Spectral Medical’s Study Highlights High-Risk Septic Shock Subgroup, Bolstering PMX Therapy Rationale
TipRanks · 09/16 12:17
Weekly Report: what happened at EDTXF last week (0908-0912)?
Weekly Report · 09/15 09:58
Spectral Medical Sponsors Unite for Sepsis Symposium, Highlights Personalized Treatment
TipRanks · 09/08 12:45
Weekly Report: what happened at EDTXF last week (0901-0905)?
Weekly Report · 09/08 10:00
More
About EDTXF
Spectral Medical Inc. is a Canada-based late-stage theranostic company focused on advancing therapeutic solutions for sepsis and septic shock. The Company develops and commercializes Toraymyxin (PMX), a therapeutic hemoperfusion device designed to remove endotoxins from the bloodstream, which are a major cause of sepsis. The Company also offers the Endotoxin Activity Assay (EAA), the diagnostic test for detecting endotoxin levels in blood, and it provides an endotoxin activity result normally between 0.0 and 1.0. It provides reagents for both research and commercial applications. Their product line includes monoclonal antibodies and recombinant proteins, which are essential for developing advanced diagnostic tools. Additionally, the Company is conducting the Tigris Clinical Trial, a confirmatory study evaluating PMX in combination with standard care versus standard care alone, using Bayesian statistical analysis.

Webull offers Spectral Medical Inc stock information, including OTCPK: EDTXF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EDTXF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading EDTXF stock methods without spending real money on the virtual paper trading platform.